Literature DB >> 17588380

Interactive effects of homocysteine and copper on angiogenesis in porcine isolated saphenous vein.

Nilima Shukla1, Gianni D Angelini, Jamie Y Jeremy.   

Abstract

BACKGROUND: After coronary artery bypass grafting procedures with saphenous vein, there is a protracted elevation of plasma homocysteine and copper. These interact to elicit endothelial dysfunction through promotion of superoxide. It has been suggested that angiogenesis and the formation of a neovasa vasorum is important in mediating vein graft patency. A novel in vitro model of angiogenesis in isolated pig saphenous veins was therefore developed to study the effect of homocysteine and copper and the role of superoxide on tubule growth, an index of angiogenesis.
METHODS: Two-millimeter rings of porcine saphenous veins were embedded in fibrin, incubated for 2 weeks with homocysteine and copper chloride, and tubules counted.
RESULTS: Tubule growth in cultured saphenous veins, which was inhibited by angiostatin, occurred in a time-dependent manner during a 14-day period. Copper chloride alone at 1 microM and 10 microM augmented microtubule formation, whereas homocysteine alone at up to 1 mM had no effect. Homocysteine and copper chloride together markedly inhibited microtubule formation. Significant inhibition of tubule formation and superoxide formation was elicited with inhibitors of nicotinamide adenine dinucleotide phosphate oxidase, mitochondrial respiration, and xanthine oxidase. Copper chloride augmented superoxide formation, but homocysteine had no effect. Homocysteine and copper chloride together also augmented superoxide formation.
CONCLUSIONS: These data indicate that the increase in plasma homocysteine and copper may exert a deleterious effect on graft patency by preventing the formation of a neovasa vasorum, thereby promoting hypoxia. This effect is mediated by a mechanism independent of superoxide which actually promotes angiogenesis in this model.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17588380     DOI: 10.1016/j.athoracsur.2007.03.087

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  7 in total

1.  Folic acid administration reduces neointimal thickening, augments neo-vasa vasorum formation and reduces oxidative stress in saphenous vein grafts from pigs used as a model of diabetes.

Authors:  J Bloor; N Shukla; F C T Smith; G D Angelini; J Y Jeremy
Journal:  Diabetologia       Date:  2010-02-25       Impact factor: 10.122

2.  Trientine selectively delivers copper to the heart and suppresses pressure overload-induced cardiac hypertrophy in rats.

Authors:  Jiaming Liu; Chen Chen; Yinjie Liu; Xiaorong Sun; Xueqin Ding; Liying Qiu; Pengfei Han; Y James Kang
Journal:  Exp Biol Med (Maywood)       Date:  2018-11-24

3.  Homocysteine injures vascular endothelial cells by inhibiting mitochondrial activity.

Authors:  Fengyong Yang; Xiujing Qi; Zheng Gao; Xingju Yang; Xingfeng Zheng; Chonghao Duan; Jian Zheng
Journal:  Exp Ther Med       Date:  2016-08-02       Impact factor: 2.447

4.  Identifying a role for the interaction of homocysteine and copper in promoting cardiovascular-related damage.

Authors:  Megha Gupta; Jiries Meehan-Atrash; Robert M Strongin
Journal:  Amino Acids       Date:  2021-04-22       Impact factor: 3.520

5.  Disturbance of copper homeostasis is a mechanism for homocysteine-induced vascular endothelial cell injury.

Authors:  Daoyin Dong; Biao Wang; Wen Yin; Xueqing Ding; Jingjing Yu; Y James Kang
Journal:  PLoS One       Date:  2013-10-18       Impact factor: 3.240

6.  Induction of apoptosis and autosis in cardiomyocytes by the combination of homocysteine and copper via NOX-mediated p62 expression.

Authors:  Ran Yin; Huan Wang; Chun Li; Lulu Wang; Songqing Lai; Xianhe Yang; Daojun Hong; Wan Zhang
Journal:  Cell Death Discov       Date:  2022-02-21

7.  Homocysteine restricts copper availability leading to suppression of cytochrome C oxidase activity in phenylephrine-treated cardiomyocytes.

Authors:  Xiao Zuo; Daoyin Dong; Miao Sun; Huiqi Xie; Y James Kang
Journal:  PLoS One       Date:  2013-06-20       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.